Skip to main content

Table 3 Risks of clinical outcomes, with and without NAI treatment, for each stratum (note that “Others” comprises the elderly, health care worker, and general population strata)

From: Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context

  

Risk

Outcome

Precondition(s)

High-risk

Children

Others

Hospitalisation

No Early Rx

1

1

1

Hospitalisation

Early Rx

0.5

1

0.84

ICU admission

Hospitalisation, No Rx

0.395

0.144

0.144

ICU admission

Hospitalisation, Rx

0.25

0.144

0.125

Death

ICU admission, No Rx

0.949

0.461

0.461

Death

ICU admission, Rx

0.6

0.461

0.4